PMLiVE 23. Dezember 2020 Abivax’s COVID-19 study declared Research National Priority by French government
European Biotechnology 1. Dezember 2020 Germany first EU country to launch COVID-19 therapy offensive?
BlastingNews 27. November 2020 A therapy, such as ABX464, treats patients that are already infected to promote recovery